1|Page
NMU MT COMPREHENSIVE EXAM-
IMMUNOHEMATOLOGY TEST WITH
ACTUAL EXAM TIPS
A woman wants to donate Exclusion due to low hematocrit
blood. Her physical
examination reveals the
following: weight—
110 pounds, pulse—73,
blood pressure—125/75,
hematocrit—
35. Which of the
following applies to
the prospective
donor?
a. Exclusion due to high pulse
b. Exclusion due to low
weight
c. Exclusion due to
low hematocrit
d. Exclusion due to high
blood pressure
e. The donor is acceptable
,2|Page
An otherwise healthy 454 ml
person wants to donate
blood.
However, the person
weighs only 95 pounds.
What is the allowable
amount of blood that
can be drawn, not
counting
blood for the pilot tubes?
a. 367 mL
b. 378 mL
c. 400 mL
d. 425 mL
e. 454 mL
,3|Page
Which of the following Recipient of human growth hormone
donors would be
deferred indefinitely?
a. History of syphilis
b. History of gonorrhea
c. Accutane treatment
d. Recipient of human
growth hormone
e. Recipient of a vaccination
Although cryoprecipitate Antithrombin III
is commonly used for
treatment of
hypofibrinogenemia and
hemophilia A, it contains
other blood proteins
useful in the
treatment of
coagulopathies. Which
of the following is not
found in
cryoprecipitate?
a. Fibronectin
b. Factor XIII
c. Factor VIII:vW
d. Antithrombin III
e. Factor VIII:C
The addition of adenine Maintaining ATP levels for red cell viability
in the CPDA-1
formulation aids in:
a. Binding calcium
b. Maintaining ATP levels
for red cell viability
c. Maintaining platelet
function in stored
blood
d. Reducing the plasma K+
levels during storage
, 4|Page
e. Maintaining 2,3-DPG
levels for oxygen release
to the tissues
A satellite bag 36%
containing 250 mL of
fresh plasma is selected
for quality control of
cryoprecipitate production.
Cyro is prepared according
to standard operating
procedures. The final
product has a total volume
of 10 mL. The factor VIII
assays are 1 IU/mL before
and 9 IU/mL after
preparation.
What is the percent yield
of factor VIII in the final
cryoprecipitate?
a. 11%
b. 25%
c. 36%
d. 52%
e. 80%
NMU MT COMPREHENSIVE EXAM-
IMMUNOHEMATOLOGY TEST WITH
ACTUAL EXAM TIPS
A woman wants to donate Exclusion due to low hematocrit
blood. Her physical
examination reveals the
following: weight—
110 pounds, pulse—73,
blood pressure—125/75,
hematocrit—
35. Which of the
following applies to
the prospective
donor?
a. Exclusion due to high pulse
b. Exclusion due to low
weight
c. Exclusion due to
low hematocrit
d. Exclusion due to high
blood pressure
e. The donor is acceptable
,2|Page
An otherwise healthy 454 ml
person wants to donate
blood.
However, the person
weighs only 95 pounds.
What is the allowable
amount of blood that
can be drawn, not
counting
blood for the pilot tubes?
a. 367 mL
b. 378 mL
c. 400 mL
d. 425 mL
e. 454 mL
,3|Page
Which of the following Recipient of human growth hormone
donors would be
deferred indefinitely?
a. History of syphilis
b. History of gonorrhea
c. Accutane treatment
d. Recipient of human
growth hormone
e. Recipient of a vaccination
Although cryoprecipitate Antithrombin III
is commonly used for
treatment of
hypofibrinogenemia and
hemophilia A, it contains
other blood proteins
useful in the
treatment of
coagulopathies. Which
of the following is not
found in
cryoprecipitate?
a. Fibronectin
b. Factor XIII
c. Factor VIII:vW
d. Antithrombin III
e. Factor VIII:C
The addition of adenine Maintaining ATP levels for red cell viability
in the CPDA-1
formulation aids in:
a. Binding calcium
b. Maintaining ATP levels
for red cell viability
c. Maintaining platelet
function in stored
blood
d. Reducing the plasma K+
levels during storage
, 4|Page
e. Maintaining 2,3-DPG
levels for oxygen release
to the tissues
A satellite bag 36%
containing 250 mL of
fresh plasma is selected
for quality control of
cryoprecipitate production.
Cyro is prepared according
to standard operating
procedures. The final
product has a total volume
of 10 mL. The factor VIII
assays are 1 IU/mL before
and 9 IU/mL after
preparation.
What is the percent yield
of factor VIII in the final
cryoprecipitate?
a. 11%
b. 25%
c. 36%
d. 52%
e. 80%